Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors. Issue 5 (May 2021)
- Record Type:
- Journal Article
- Title:
- Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors. Issue 5 (May 2021)
- Main Title:
- Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors
- Authors:
- Baretti, Marina
Zhu, Qingfeng
Zahurak, Marianna
Bhaijee, Feriyl
Xu, Haiying
Engle, Elizabeth L.
Kotte, Anil
Pawlik, Timothy M.
Anders, Robert A.
De Jesus-Acosta, Ana - Abstract:
- Abstract : Objectives: The aim of this study was to characterize the tumor microenvironment of patients with gastroenteropancreatic neuroendocrine tumors relative to progression-free survival (PFS). Methods: Immune profiling for CD3, CD8, programmed death-1/programmed death-ligand 1, and indoleamine 2, 3-dioxygenase expression in 2 cohorts of gastroenteropancreatic neuroendocrine tumors: patients with short PFS (<4 years, n = 12) versus long PFS (≥4 years, n = 14) after surgery. Immune infiltrates in the tumor and interface were quantified. Programmed death-ligand 1 expression was determined within the tumor, stroma, and interface. Results: Patients with shorter PFS had larger tumors ( P = 0.02), mostly in the pancreas ( P = 0.04). We observed a higher mean expression of CD3 +, CD8 +, programmed death-1 + cells, and indoleamine 2, 3-dioxygenase at the interface compared with the tumor: log 10 mean differences 0.56 (95% confidence interval [CI], 0.43–0.68; P < 0.0001), 0.45 (95% CI, 0.32–0.59; P = 0.0002), 0.50 (95% CI, 0.40–0.61; P < 0.0001), and 0.24 (95% CI, 0.03–0.46; P = 0.046), respectively. Patients with longer PFS had higher intratumoral CD3 + T cells, log 10 mean difference 0.38 (95% CI, 0.19–0.57; P = 0.004). Programmed death-ligand 1 expression tended to be higher among patients with shortened PFS (odds ratio, 2.00; 95% CI, 0.68–5.91). Conclusions: Higher intratumoral CD3 + T-cell infiltrate was associated with longer PFS after resection. Abstract : SupplementalAbstract : Objectives: The aim of this study was to characterize the tumor microenvironment of patients with gastroenteropancreatic neuroendocrine tumors relative to progression-free survival (PFS). Methods: Immune profiling for CD3, CD8, programmed death-1/programmed death-ligand 1, and indoleamine 2, 3-dioxygenase expression in 2 cohorts of gastroenteropancreatic neuroendocrine tumors: patients with short PFS (<4 years, n = 12) versus long PFS (≥4 years, n = 14) after surgery. Immune infiltrates in the tumor and interface were quantified. Programmed death-ligand 1 expression was determined within the tumor, stroma, and interface. Results: Patients with shorter PFS had larger tumors ( P = 0.02), mostly in the pancreas ( P = 0.04). We observed a higher mean expression of CD3 +, CD8 +, programmed death-1 + cells, and indoleamine 2, 3-dioxygenase at the interface compared with the tumor: log 10 mean differences 0.56 (95% confidence interval [CI], 0.43–0.68; P < 0.0001), 0.45 (95% CI, 0.32–0.59; P = 0.0002), 0.50 (95% CI, 0.40–0.61; P < 0.0001), and 0.24 (95% CI, 0.03–0.46; P = 0.046), respectively. Patients with longer PFS had higher intratumoral CD3 + T cells, log 10 mean difference 0.38 (95% CI, 0.19–0.57; P = 0.004). Programmed death-ligand 1 expression tended to be higher among patients with shortened PFS (odds ratio, 2.00; 95% CI, 0.68–5.91). Conclusions: Higher intratumoral CD3 + T-cell infiltrate was associated with longer PFS after resection. Abstract : Supplemental digital content is available in the text. … (more)
- Is Part Of:
- Pancreas. Volume 50:Issue 5(2021)
- Journal:
- Pancreas
- Issue:
- Volume 50:Issue 5(2021)
- Issue Display:
- Volume 50, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 50
- Issue:
- 5
- Issue Sort Value:
- 2021-0050-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-05
- Subjects:
- spatial architecture -- tumor-infiltrating lymphocytes -- PD-1 -- PD-L1 -- GEP-NETs -- prognosis
Pancreas -- Diseases -- Periodicals
Pancreas -- Periodicals
Neuroendocrine tumors -- Periodicals
616.37005 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00006676-000000000-00000 ↗
http://www.pancreasjournal.com ↗
http://journals.lww.com/pancreasjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPA.0000000000001831 ↗
- Languages:
- English
- ISSNs:
- 0885-3177
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6357.351500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18961.xml